Maynard Um
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Raised to $300 at B.Riley
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Raised to $270 at H.C. Wainwright
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Raised to $259 at UBS
-
-
-
-
-
-
-
Mizuho stays Outperform on Axsome Therapeutics (AXSM) as Auvelity Rx growth accelerates
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Raised to $215 at TD Cowen
-
-
-
-
-
-
-
Axsome Therapeutics reports preliminary 2025 revenue of $638.5 million
-
-
-
-
-
-
-
Baird on Axsome Therapeutics (AXSM): 'Incrementally positive on regulatory updates'
-
401,554 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

